These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 53014)
21. [Attempt to isolate an active enzyme fraction for use in the treatment of schizophrenia]. Fromen Ch; Gottlib D Vestn Akad Med Nauk SSSR; 1975; (9):51-5. PubMed ID: 59494 [No Abstract] [Full Text] [Related]
22. Conformation of a unique plasma protein in schizophrenia. Frohman CE; Harmison CR; Arthur RE; Gottlieb JS Biol Psychiatry; 1971; 3(2):113-21. PubMed ID: 4103784 [No Abstract] [Full Text] [Related]
23. Correlations between clinical and biochemical data in schizophrenia. Arnold OH; Hofmann G Behav Neuropsychiatry; 1972; 3(11-12):18-24. PubMed ID: 5018268 [No Abstract] [Full Text] [Related]
30. Studies in schizophrenia, V. Disturbances of protein and tryptophan metabolism and toxicity of urine. FLEISCHHACKER HH; LANCASTER JB; WHEELER AP J Ment Sci; 1959 Apr; 105(439):313-25. PubMed ID: 13665293 [No Abstract] [Full Text] [Related]
31. Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia. Yao JK; Magan S; Sonel AF; Gurklis JA; Sanders R; Reddy RD Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):171-6. PubMed ID: 15253886 [TBL] [Abstract][Full Text] [Related]
32. [Biochemical aspects of involuntary movements (author's transl)]. Nakamura S; Kameyama M No To Shinkei; 1981 Dec; 33(12):1177-85. PubMed ID: 7034752 [No Abstract] [Full Text] [Related]
33. Plasma factor in schizophrenia. Frohman CE Biol Psychiatry; 1976 Apr; 11(2):251-2. PubMed ID: 61046 [No Abstract] [Full Text] [Related]
34. Metabolic aspects of shock. Schumer W Surg Annu; 1974; 6():1-16. PubMed ID: 4139771 [No Abstract] [Full Text] [Related]
35. [Biochemical study of a schizophreniac]. Caridroit M; Duc-Aublet F; Testegute T; Miens C; Fontan M; Caridroit M Lille Med; 1973 Dec; 18(10):1186-201. PubMed ID: 4794244 [No Abstract] [Full Text] [Related]
36. [Differences in serotonin and dopamine metabolism in psychopathy and sluggish schizophrenia]. Zabrodin GD; Turova ZG Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(11):1673-7. PubMed ID: 1015096 [TBL] [Abstract][Full Text] [Related]
37. Alterations of serotonin transmission in schizophrenia. Abi-Dargham A Int Rev Neurobiol; 2007; 78():133-64. PubMed ID: 17349860 [TBL] [Abstract][Full Text] [Related]
38. Differences in the natural autoantibody patterns of patients with schizophrenia and normal individuals. Lévy-Soussan P; Berneman A; Poirier MF; Galinowski A; Loo H; Olié JP; Avrameas S J Psychiatry Neurosci; 1996 Mar; 21(2):89-95. PubMed ID: 8820173 [TBL] [Abstract][Full Text] [Related]
39. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Miller CL; Llenos IC; Cwik M; Walkup J; Weis S Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600 [TBL] [Abstract][Full Text] [Related]